Meta-analyses based on 18 #randomized #controlled #treatment trials of #ivermectin in #COVID-19 have found large, statistically #significant #reductions in #mortality, time to clinical recovery, and time to #viral clearance. Furthermore, results from numerous controlled #prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin. Finally, the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.
There are no comments yet.